[ad_1] TEL AVIV (Reuters) – Israel's RedHill Biopharma said on Monday it had positive safety and efficacy results from a late-stage clinical trial with Crohn's disease called RHB-104. The study puts its …
Read More »[ad_1] TEL AVIV (Reuters) – Israel's RedHill Biopharma said on Monday it had positive safety and efficacy results from a late-stage clinical trial with Crohn's disease called RHB-104. The study puts its …
Read More »